ArticleEBioMedicine2019

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.

Hangzhan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.